Effect of nabumetone treatment on vascular responses of the thoracic aorta in rat experimental arthritis

Pharmacology

Volumn 60, Issue 3, 2000, Pages 136-142

  Ülker, Sibel ^a   Önal, Aytül ^a   Hatip, Funda Bölükbaşi ^b   Sürücü, Ayşe ^a   Alkanat, Murat ^a   Koşay, Sezen ^a   Evinç, Akgün ^a  

^a EGE UNIVERSITY   (Turkey)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Adjuvant arthritis; Cyclooxygenase; Nabumetone; Vascular contraction; Vascular relaxation

Indexed keywords

ACETYLCHOLINE; NABUMETONE; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLEPHRINE; POTASSIUM CHLORIDE;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; GASTRODUODENAL ULCER; HISTOPATHOLOGY; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASOCONSTRICTION; VASODILATATION;

EID: 0343183962     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028358     Document Type: Article

References (21)

1. Brahn E: Animal models of rheumatoid arthritis. Clues to etiology and treatment. Clin Orthop 1991;265:42-50.
2. Floman Y, Okon E, Zor R: The role of prostaglandin in experimental arthritis in the rat. Clin Orthop 1977;125:214-220.
3. Issekutz AC, Movat HZ: The effect of vasodilator prostaglandins on polymorphonuclear leukocyte infiltration and vascular injury. Am J Pathol 1982;107:300-309.
4. Simmons DL, Xie W, Chipman JG, Evett GE: Multiple cyclooxygenases: Cloning of a mitogen-inducible form; in Bailey JM (ed): Prostaglandins, Leukotrienes, Lipoxins and PAF. New York, Plenum Press, 1991, pp 67-78.
5. Dandano P, Jeremy JY: Nonsteroidal antiinflammatory drug therapy and gastric side effects; does nabumetone provide a solution? Drugs 1990;40(suppl 5):16-24.
6. Dewitt DL, Meade EA, Smith WL: PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal antiinflammatory drugs. Am J Med 1993;95(suppl 2A):40S-44S.
7. Klein T, Nüsing RM, Pfeilschifter J, Ullrich V: Selective inhibition of cyclooxygenase. Biochem Pharmacol 1994;48:1605-1610.
8. Çmar MG, Can C, Ülker S, Gök Ş, Çoker C, Soykan N, Koşay S, Evinç A: Effect of vitamin E on vascular responses of thoracic aorta in rat experimental arthritis. Gen Pharmacol 1998; 31:149-153.
9. Issekutz AC: Vascular responses during acute neutrophil emigration. Their relationship to in vivo neutrophil emigration. Lab Invest 1981; 45:435-441.
10. Fang ZY, Fontaine J, Unger PH, Berkenboom G: Alterations of the endothelial function of isolated aorta in rats with adjvuant arthritis. Arch Int Pharmacodyn Ther 1991;311:122-130.
11. Pang L, Knox AJ: Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Br J Pharmacol 1997;121:579-587.
12. Tesfamariam B, Cohen RA: Role of superoxide anion and endothelium in vasoconstrictor action of prostaglandin endoperoxide. Am J Physiol 1992;262:H1915-H1919.
13. Rofe AM, Philcox JC, Haynes DR, Coyle P: Wasting in adjuvant-induced arthritis and its relationship to plasma zinc, copper and liver metallothionein. Agents Actions 1994;42:60-62.
14. Ohkawa F, Ikeda U, Kanbe T, Kawasaki K, Shimada L: Inflammatory cytokines and rat vascular tone. Clin Exp Pharmacol Physiol 1995;(suppl 1):S169-S171.
15. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughley DA: Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91:2046-2050.
16. Goodwin JS: Are prostaglandins proinflammatory, antiinflammatory, both or neither? J Rheumatol Suppl 1991;28:26-29.
17. Bensen W, Zizzo A: Newer, safer nonsteroidal anti-inflammatory drugs. Rational NSAID selection for arthritis. Can Fam Phys 1998;44: 101-102.
18. Roth SH: Endoscopy-controlled study of the safety of nabumetone compared with naproxen in arthritis therapy. Am J Med 1987;83(suppl 4B):25-30.
19. Fleischmann RM: Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis. J Rheumatol 1992;19(suppl 36): 32-40.
20. Melerange R, Gentry C, O'Connell C, Blower PR, Neil C, Kelvin AS, Toseland CDN: Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphtylacetic acid (6MNA): Comparative studies with indomethacin. Dig Dis Sci 1992; 37:1847-1852.
21. Davies NM: Clinical pharmacokinetics of nabumetone. The dawn of selective cyclooxygenase-2. Clin Pharmacokinet 1997;33:403-416.